1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6038630B3532A217F85257DC600673963
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/patient-support-excellence-program-staffing-and-budget
18
19
2018.212.90.230
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Patient Advocacy

Patient Support Excellence: Program Staffing and Budget

ID: 5344


Features:

12 Info Graphics

18 Data Graphics

130+ Metrics

2 Narratives


Pages/Slides: 39


Published: 2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Patient Support Excellence: Program Staffing and Budget"



Study Overview

Facing declining sales from patent losses and payer pressures, the pharmaceutical sector is turning to patient support programs and activities to help drive clinical and commercial success. As pharma has invested in patient support programs, staffing and budget levels have increased but it is unclear what resource levels are appropriate - or increase effectiveness - for this rising function.


Best Practices, LLC conducted this study to generate reliable industry metrics on current patient support group staffing and budget levels. In particular, the study reviews current drivers for patient support programs, current staffing metrics and budget sources and levels. This benchmarking study will provide patient support leaders with metrics and insights they can use to assess their patient support operations' staffing and budget levels.

This study has small, medium and large company segments on some questions


Key Topics

  • Patient Support in Pharma
  • Staffing and Program Drivers
  • Program Staffing
  • Program Budget

Sample Key Metrics
  • Reasons driving your organization to provide patient support programs
  • Factors influencing the development of new patient support programs
  • Factors influencing the level of staffing for patient support programs
  • FTEs allocated to patient support for your area of responsibility and company-wide
  • FTEs allocated to patient support for your area of responsibility and company-wide - segmented by self-rating of program effectiveness
  • FTEs allocated to patient support for your area of responsibility and company-wide - segmented by patient support organizational structure
  • Functional groups that provide funding for your patient support program
  • Total budget for patient support initiatives for your area of responsibility and company-wide patient support
  • Percentage of marketing budget allocated for patient support initiatives

Sample Key Finding
  • Brand Teams Principal Funding Source for Patient Support Programs: 47% of respondents said brand/product teams were their Patient Support programs’ principal funder. Company-wide business units were the next largest principal funder at 41%. Meanwhile, a majority said medical was not a contributor to their program.
  • A majority of Patient Support programs rated as “Very Good” receive their primary funding from company-wide business units.
  • Most of the Patient Support programs that were rated “Good” or “So-So” receive their primary funding from brand or product teams.
  • By Company Size: LCS = 57% brand/product team is principal funder; MCS = 75% company-wide business units are principal funders; SCS = 50% company-wide business units are principal funder. (42%).

Study Methodology

Nineteen Patient Support leaders from 19 different companies participated in this study. Participants were recruited because of their involvement in Patient Support programs.

Industries Profiled:
Health Care; Pharmaceutical; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Medical Device; Chemical


Companies Profiled:
Sanofi; Merck; GlaxoSmithKline ; Novo Nordisk; Daiichi Sankyo; Pfizer; Boehringer Ingelheim; AstraZeneca; Astellas; Baxter Healthcare; EMD Serono; Merck Serono; Celgene; UCB Pharma; Millenium; Dr Reddy's Laboratories; Roche; LEO Pharma; Horizon Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.